
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
FcγR-mediated SARS-CoV-2 infection of monocytes activates inflammation
Caroline Junqueira, Ângela C. Crespo, Shahin Ranjbar, et al.
Nature (2022) Vol. 606, Iss. 7914, pp. 576-584
Open Access | Times Cited: 440
Caroline Junqueira, Ângela C. Crespo, Shahin Ranjbar, et al.
Nature (2022) Vol. 606, Iss. 7914, pp. 576-584
Open Access | Times Cited: 440
Showing 1-25 of 440 citing articles:
A 360° view of the inflammasome: Mechanisms of activation, cell death, and diseases
Katherine C. Barnett, Sirui Li, Kaixin Liang, et al.
Cell (2023) Vol. 186, Iss. 11, pp. 2288-2312
Closed Access | Times Cited: 207
Katherine C. Barnett, Sirui Li, Kaixin Liang, et al.
Cell (2023) Vol. 186, Iss. 11, pp. 2288-2312
Closed Access | Times Cited: 207
The humoral response and antibodies against SARS-CoV-2 infection
Hai Qi, Bo Liu, Xinquan Wang, et al.
Nature Immunology (2022) Vol. 23, Iss. 7, pp. 1008-1020
Open Access | Times Cited: 144
Hai Qi, Bo Liu, Xinquan Wang, et al.
Nature Immunology (2022) Vol. 23, Iss. 7, pp. 1008-1020
Open Access | Times Cited: 144
Origin, virological features, immune evasion and intervention of SARS-CoV-2 Omicron sublineages
Shuai Xia, Lijue Wang, Yun Zhu, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 134
Shuai Xia, Lijue Wang, Yun Zhu, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 134
SARS-CoV-2 drives NLRP3 inflammasome activation in human microglia through spike protein
Eduardo A. Albornoz, Alberto A. Amarilla, Naphak Modhiran, et al.
Molecular Psychiatry (2022) Vol. 28, Iss. 7, pp. 2878-2893
Open Access | Times Cited: 126
Eduardo A. Albornoz, Alberto A. Amarilla, Naphak Modhiran, et al.
Molecular Psychiatry (2022) Vol. 28, Iss. 7, pp. 2878-2893
Open Access | Times Cited: 126
Beyond neutralization: Fc-dependent antibody effector functions in SARS-CoV-2 infection
Ali Zhang, Hannah D. Stacey, Michael R. D’Agostino, et al.
Nature reviews. Immunology (2022) Vol. 23, Iss. 6, pp. 381-396
Open Access | Times Cited: 124
Ali Zhang, Hannah D. Stacey, Michael R. D’Agostino, et al.
Nature reviews. Immunology (2022) Vol. 23, Iss. 6, pp. 381-396
Open Access | Times Cited: 124
Antibody-mediated neutralization of SARS-CoV-2
Henning Gruell, Kanika Vanshylla, Timm Weber, et al.
Immunity (2022) Vol. 55, Iss. 6, pp. 925-944
Open Access | Times Cited: 117
Henning Gruell, Kanika Vanshylla, Timm Weber, et al.
Immunity (2022) Vol. 55, Iss. 6, pp. 925-944
Open Access | Times Cited: 117
Immune response in COVID-19: what is next?
Qing Li, Ying Wang, Qiang Sun, et al.
Cell Death and Differentiation (2022) Vol. 29, Iss. 6, pp. 1107-1122
Open Access | Times Cited: 110
Qing Li, Ying Wang, Qiang Sun, et al.
Cell Death and Differentiation (2022) Vol. 29, Iss. 6, pp. 1107-1122
Open Access | Times Cited: 110
The NLRP3 inflammasome: contributions to inflammation-related diseases
Ying Chen, Xingyan Ye, Germaine Escames, et al.
Cellular & Molecular Biology Letters (2023) Vol. 28, Iss. 1
Open Access | Times Cited: 110
Ying Chen, Xingyan Ye, Germaine Escames, et al.
Cellular & Molecular Biology Letters (2023) Vol. 28, Iss. 1
Open Access | Times Cited: 110
Long COVID endotheliopathy: hypothesized mechanisms and potential therapeutic approaches
Jasimuddin Ahamed, Jeffrey Laurence
Journal of Clinical Investigation (2022) Vol. 132, Iss. 15
Open Access | Times Cited: 102
Jasimuddin Ahamed, Jeffrey Laurence
Journal of Clinical Investigation (2022) Vol. 132, Iss. 15
Open Access | Times Cited: 102
Tixagevimab–cilgavimab for treatment of patients hospitalised with COVID-19: a randomised, double-blind, phase 3 trial
Thomas L Holland, Adit A. Ginde, Roger Paredes, et al.
The Lancet Respiratory Medicine (2022) Vol. 10, Iss. 10, pp. 972-984
Open Access | Times Cited: 99
Thomas L Holland, Adit A. Ginde, Roger Paredes, et al.
The Lancet Respiratory Medicine (2022) Vol. 10, Iss. 10, pp. 972-984
Open Access | Times Cited: 99
COVID-19 and cellular senescence
Clemens A. Schmitt, Tamar Tchkonia, Laura J. Niedernhofer, et al.
Nature reviews. Immunology (2022) Vol. 23, Iss. 4, pp. 251-263
Open Access | Times Cited: 99
Clemens A. Schmitt, Tamar Tchkonia, Laura J. Niedernhofer, et al.
Nature reviews. Immunology (2022) Vol. 23, Iss. 4, pp. 251-263
Open Access | Times Cited: 99
SARS-CoV-2-specific T cells in the changing landscape of the COVID-19 pandemic
Antonio Bertoletti, Nina Le Bert, Anthony T. Tan
Immunity (2022) Vol. 55, Iss. 10, pp. 1764-1778
Open Access | Times Cited: 92
Antonio Bertoletti, Nina Le Bert, Anthony T. Tan
Immunity (2022) Vol. 55, Iss. 10, pp. 1764-1778
Open Access | Times Cited: 92
SARS-CoV-2 infection drives an inflammatory response in human adipose tissue through infection of adipocytes and macrophages
Giovanny J. Martínez-Colón, Kalani Ratnasiri, Richard Chen, et al.
Science Translational Medicine (2022) Vol. 14, Iss. 674
Open Access | Times Cited: 84
Giovanny J. Martínez-Colón, Kalani Ratnasiri, Richard Chen, et al.
Science Translational Medicine (2022) Vol. 14, Iss. 674
Open Access | Times Cited: 84
Fc-γR-dependent antibody effector functions are required for vaccine-mediated protection against antigen-shifted variants of SARS-CoV-2
Samantha Mackin, Pritesh Desai, Bradley Whitener, et al.
Nature Microbiology (2023) Vol. 8, Iss. 4, pp. 569-580
Open Access | Times Cited: 83
Samantha Mackin, Pritesh Desai, Bradley Whitener, et al.
Nature Microbiology (2023) Vol. 8, Iss. 4, pp. 569-580
Open Access | Times Cited: 83
Neuroinflammation and COVID-19
Abigail Vanderheiden, Robyn S. Klein
Current Opinion in Neurobiology (2022) Vol. 76, pp. 102608-102608
Open Access | Times Cited: 78
Abigail Vanderheiden, Robyn S. Klein
Current Opinion in Neurobiology (2022) Vol. 76, pp. 102608-102608
Open Access | Times Cited: 78
Innate metabolic responses against viral infections
Clovis S. Palmer
Nature Metabolism (2022) Vol. 4, Iss. 10, pp. 1245-1259
Open Access | Times Cited: 72
Clovis S. Palmer
Nature Metabolism (2022) Vol. 4, Iss. 10, pp. 1245-1259
Open Access | Times Cited: 72
Innate immunity, cytokine storm, and inflammatory cell death in COVID-19
Rajendra Karki, Thirumala‐Devi Kanneganti
Journal of Translational Medicine (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 72
Rajendra Karki, Thirumala‐Devi Kanneganti
Journal of Translational Medicine (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 72
Home as the new frontier for the treatment of COVID-19: the case for anti-inflammatory agents
Norberto Perico, Monica Cortinovis, Fredy Suter, et al.
The Lancet Infectious Diseases (2022) Vol. 23, Iss. 1, pp. e22-e33
Open Access | Times Cited: 66
Norberto Perico, Monica Cortinovis, Fredy Suter, et al.
The Lancet Infectious Diseases (2022) Vol. 23, Iss. 1, pp. e22-e33
Open Access | Times Cited: 66
Antiviral neutralizing antibodies: from in vitro to in vivo activity
Dennis R. Burton
Nature reviews. Immunology (2023) Vol. 23, Iss. 11, pp. 720-734
Open Access | Times Cited: 61
Dennis R. Burton
Nature reviews. Immunology (2023) Vol. 23, Iss. 11, pp. 720-734
Open Access | Times Cited: 61
Gasdermin D-mediated pyroptosis: mechanisms, diseases, and inhibitors
Zhen Dai, Wan-Cong Liu, Xiaoyi Chen, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 59
Zhen Dai, Wan-Cong Liu, Xiaoyi Chen, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 59
Immune mechanisms underlying COVID-19 pathology and post-acute sequelae of SARS-CoV-2 infection (PASC)
Sindhu Mohandas, Prasanna Jagannathan, Timothy J. Henrich, et al.
eLife (2023) Vol. 12
Open Access | Times Cited: 59
Sindhu Mohandas, Prasanna Jagannathan, Timothy J. Henrich, et al.
eLife (2023) Vol. 12
Open Access | Times Cited: 59
SARS-CoV-2 and innate immunity: the good, the bad, and the “goldilocks”
Benjamín L. Sievers, Mark T. K. Cheng, Kata Csiba, et al.
Cellular and Molecular Immunology (2023) Vol. 21, Iss. 2, pp. 171-183
Open Access | Times Cited: 44
Benjamín L. Sievers, Mark T. K. Cheng, Kata Csiba, et al.
Cellular and Molecular Immunology (2023) Vol. 21, Iss. 2, pp. 171-183
Open Access | Times Cited: 44
Effect of posttranslational modifications and subclass on IgG activity: from immunity to immunotherapy
Falk Nimmerjahn, Gestur Vidarsson, Mark S. Cragg
Nature Immunology (2023) Vol. 24, Iss. 8, pp. 1244-1255
Closed Access | Times Cited: 43
Falk Nimmerjahn, Gestur Vidarsson, Mark S. Cragg
Nature Immunology (2023) Vol. 24, Iss. 8, pp. 1244-1255
Closed Access | Times Cited: 43
Inflammasomes in neurological disorders — mechanisms and therapeutic potential
Kishore Aravind Ravichandran, Michael T. Heneka
Nature Reviews Neurology (2024) Vol. 20, Iss. 2, pp. 67-83
Closed Access | Times Cited: 33
Kishore Aravind Ravichandran, Michael T. Heneka
Nature Reviews Neurology (2024) Vol. 20, Iss. 2, pp. 67-83
Closed Access | Times Cited: 33
Mechanisms of long COVID and the path toward therapeutics
Michael J. Peluso, Steven G. Deeks
Cell (2024)
Open Access | Times Cited: 23
Michael J. Peluso, Steven G. Deeks
Cell (2024)
Open Access | Times Cited: 23